Status:
UNKNOWN
A High-PRotein Mediterranean Diet and Resistance Exercise for Cardiac Rehabilitation
Lead Sponsor:
Liverpool John Moores University
Collaborating Sponsors:
University of Chester
Conditions:
Cardiovascular Diseases
Sarcopenic Obesity
Eligibility:
All Genders
30-100 years
Phase:
NA
Brief Summary
Cardiovascular disease is responsible for a quarter of all deaths in the UK and risk seems to be higher in cardiac rehabilitation (CR) with lower body weight which may be due to sarcopenci obesity (SO...
Detailed Description
BACKGROUND Cardiovascular disease (CVD) in the UK is behind 1 in 4 deaths/year (\>150,000 people), with coronary heart disease (CHD) being the most common type \[1\]. In addition to the loss of life, ...
Eligibility Criteria
Inclusion
- Stage 1:
- Informed consent given
- Referral to cardiac rehabilitation program
- Ability to attend screening at Liverpool John Moores University
- Stage 2:
- Informed consent given
- Meeting selected criteria to define sarcopenic obesity (dependent on analysis from stage 1)
- Ability to attend screening at Liverpool John Moores University
- Cardiac function deemed stable after phase 3 cardiac rehabilitation
Exclusion
- Inability to perform resistance exercise (determined by primary care team)
- Renal dysfunction
- Inability/unwillingness to digest/consume dairy products
- Admission to CR due to congenital or drug/alcohol-abuse induced cardiac events
- Pregnancy
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04272073
Start Date
May 9 2022
End Date
February 1 2024
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Knowsley Community Cardiovascular Services
Liverpool, United Kingdom